Stocks News

LAST PRICE
208.4400
TODAY'S CHANGE (%)
Trending Down-1.2800 (-0.6103%)

Bid / Lots
205.8300/ 1
Ask / Lots
246.0000/ 1
Open / Previous Close
209.9000 / 209.7200
Day Range
Low 206.3900
High 211.6900
52 Week Range
Low 161.6500
High 275.0000
Volume
762,316
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 30, 2024
- Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development, from 8:00AM ET on Thursday May 30, 2024 by Business Wire
  8:00AM ET on Thursday May 30, 2024 by Business Wire
  Companies Mentioned: CRL
  Charles River Laboratories International, Inc. (NYSE: CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks. Based on decades of viral vector contract development and manufacturing organization (CDMO) experience, the Company has designed a methodical program to drive successful, accelerated process transfer to its Maryland-based viral vector center of excellence (CoE) in as little as nine months.
- Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development, from 8:00AM ET on Thursday May 30, 2024 by Dow Jones
  8:00AM ET on Thursday May 30, 2024 by Dow Jones
  Companies Mentioned: CRL
  
  Fast Track and Modular frameworks facilitate product development continuity via seamless process transfer to the Company's viral vector Center of Excellence
  WILMINGTON, Mass.--(BUSINESS WIRE)--May 30, 2024--
May 29, 2024
- Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 12:18PM ET on Wednesday May 29, 2024 by GlobeNewswire
  12:18PM ET on Wednesday May 29, 2024 by GlobeNewswire
  Companies Mentioned: RILY, VTNR, SMR, CRL
- Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 12:18PM ET on Wednesday May 29, 2024 by Dow Jones
  12:18PM ET on Wednesday May 29, 2024 by Dow Jones
  Companies Mentioned: RILY, VTNR, SMR, CRL
  
  Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
May 22, 2024
- Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 12:11PM ET on Wednesday May 22, 2024 by GlobeNewswire
  12:11PM ET on Wednesday May 22, 2024 by GlobeNewswire
  Companies Mentioned: RILY, VTNR, SMR, CRL

Yesterday
- BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing, from 3:38AM ET on Friday May 31, 2024 by MT Newswires
  3:38AM ET on Friday May 31, 2024 by MT Newswires
  Companies Mentioned: BMRN
May 30, 2024
- Incyte Completes Acquisition of Escient Pharmaceuticals, from 4:05PM ET on Thursday May 30, 2024 by Business Wire
  4:05PM ET on Thursday May 30, 2024 by Business Wire
  Companies Mentioned: INCY
May 24, 2024
- Sector Update: Health Care Stocks Advance Pre-Bell Friday, from 9:16AM ET on Friday May 24, 2024 by MT Newswires
  9:16AM ET on Friday May 24, 2024 by MT Newswires
  Companies Mentioned: EXAS, IBB, XLV, VSTM, GH
- Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test, from 8:31AM ET on Friday May 24, 2024 by MT Newswires
  8:31AM ET on Friday May 24, 2024 by MT Newswires
  Companies Mentioned: EXAS
May 23, 2024
- Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target, from 8:53AM ET on Thursday May 23, 2024 by MT Newswires
  8:53AM ET on Thursday May 23, 2024 by MT Newswires
  Companies Mentioned: INCY
May 21, 2024
- Incyte Acquires 2 Office Buildings in Delaware, from 1:54PM ET on Tuesday May 21, 2024 by MT Newswires
  1:54PM ET on Tuesday May 21, 2024 by MT Newswires
  Companies Mentioned: INCY
- Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings, from 1:15PM ET on Tuesday May 21, 2024 by Business Wire
  1:15PM ET on Tuesday May 21, 2024 by Business Wire
  Companies Mentioned: INCY
- Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed, from 8:56AM ET on Tuesday May 21, 2024 by MT Newswires
  8:56AM ET on Tuesday May 21, 2024 by MT Newswires
  Companies Mentioned: EXAS
- Incyte to Present at Upcoming Investor Conference, from 8:00AM ET on Tuesday May 21, 2024 by Business Wire
  8:00AM ET on Tuesday May 21, 2024 by Business Wire
  Companies Mentioned: INCY
May 17, 2024
- --Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 7:29AM ET on Friday May 17, 2024 by MT Newswires
  7:29AM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: BMRN

Charles River Laboratories International Inc
NYSE:CRLUnited States

Search Criteria

May 30, 2024

Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development, from 8:00AM ET on Thursday May 30, 2024 by Business Wire

Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development, from 8:00AM ET on Thursday May 30, 2024 by Dow Jones

May 29, 2024

Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 12:18PM ET on Wednesday May 29, 2024 by GlobeNewswire

Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 12:18PM ET on Wednesday May 29, 2024 by Dow Jones

May 22, 2024

Investigation Alert: NuScale Power, B. Riley Financial, Charles River Laboratories, and Vertex Energy - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 12:11PM ET on Wednesday May 22, 2024 by GlobeNewswire

Peers Headlines

Yesterday

BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing, from 3:38AM ET on Friday May 31, 2024 by MT Newswires

May 30, 2024

Incyte Completes Acquisition of Escient Pharmaceuticals, from 4:05PM ET on Thursday May 30, 2024 by Business Wire

May 24, 2024

Sector Update: Health Care Stocks Advance Pre-Bell Friday, from 9:16AM ET on Friday May 24, 2024 by MT Newswires

Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test, from 8:31AM ET on Friday May 24, 2024 by MT Newswires

May 23, 2024

Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target, from 8:53AM ET on Thursday May 23, 2024 by MT Newswires

May 21, 2024

Incyte Acquires 2 Office Buildings in Delaware, from 1:54PM ET on Tuesday May 21, 2024 by MT Newswires

Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings, from 1:15PM ET on Tuesday May 21, 2024 by Business Wire

Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed, from 8:56AM ET on Tuesday May 21, 2024 by MT Newswires

Incyte to Present at Upcoming Investor Conference, from 8:00AM ET on Tuesday May 21, 2024 by Business Wire

May 17, 2024

--Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 7:29AM ET on Friday May 17, 2024 by MT Newswires